Immunomodulation by a combination of nitric oxide and glucocorticoids in a human endotoxin model

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 1, 2011, Pages 20-27

  Hallstrom L ^a   Berghall E ^a   Frostell, C ^a   Sollevi, A ^a   Soop, A L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; HYDROCORTISONE SODIUM SUCCINATE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; NITRIC OXIDE; NITROGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOMODULATION; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADULT; BLOOD CELL COUNT; BODY TEMPERATURE; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; ENDOTOXEMIA; ENDOTOXINS; FEMALE; GLUCOCORTICOIDS; HEART RATE; HUMANS; HYDROCORTISONE; IMMUNOMODULATION; INFLAMMATION; INJECTIONS, INTRAVENOUS; MALE; NITRIC OXIDE; YOUNG ADULT;

EID: 78649982114     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02297.x     Document Type: Article

References (39)

1. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G., Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31: 2316-23.
2. Ulevitch RJ, Tobias PS., Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-57.
3. Hawiger J., Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 2001; 23: 99-109.
4. Yang H, Wang H, Czura CJ, Tracey KJ., The cytokine activity of HMGB1. J Leuk Biol 2005; 78: 1-8.
5. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ., HMG-1 as a late mediator of endotoxin lethality in mice. Science (New York) 1999; 285: 248-51.
6. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ., Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296-301.
7. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9.
8. Radomski MW, Palmer RM, Moncada S., The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-46.
9. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, Kubes P., Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998; 101: 2497-505.
10. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K Jr, Kelly KM, Smith TC, Small RJ., Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. J Am Med Assoc 2004; 291: 1603-9.
11. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot-Pocidalo MA, Payen DM., Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996; 153: 985-90.
12. Kang JL, Park W, Pack IS, Lee HS, Kim MJ, Lim CM, Koh Y., Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation. J Appl Physiol 2002; 92: 795-801.
13. Zeidler PC, Millecchia LM, Castranova V., Role of inducible nitric oxide synthase-derived nitric oxide in lipopolysaccharide plus interferon-gamma- induced pulmonary inflammation. Toxicol Appl Pharmacol 2004; 195: 45-54. (Pubitemid 38177498)
14. Adcock IM, Caramori G., Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001; 79: 376-84.
15. Cao L, Qian LL, Zhu YR, Guo CB, Gong XH, Sun B., Regulation of activity of nuclear factor-kappaB and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacol Sin 2003; 24: 1316-23.
16. Da J, Chen L, Hedenstierna G., Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit Care Med 2007; 35: 26-32.
17. Hallstrom L, Berghall E, Frostell C, Sollevi A, Soop AL., Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia. Crit Care Med 2008; 36: 3043-7.
18. Liang M, Klakamp SL, Funelas C, Lu H, Lam B, Herl C, Umble A, Drake AW, Pak M, Ageyeva N, Pasumarthi R, Roskos LK., Detection of high- and low-affinity antibodies against a human monoclonal antibody using various technology platforms. Assay Drug Dev Technol 2007; 5: 655-62.
19. Pompe JC, Kox M, Hoedemaekers CW, Van Der Hoeven JG, Pickkers P., Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia: it takes not always two to tango. Crit Care Med 2009; 37: 2676; author reply 76-7.
20. Umbreit J., Methemoglobin-it's not just blue: a concise review. Am J Hematol 2007; 82: 134-44.
21. Hataishi R, Rodrigues AC, Neilan TG, Morgan JG, Buys E, Shiva S, Tambouret R, Jassal DS, Raher MJ, Furutani E, Ichinose F, Gladwin MT, Rosenzweig A, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M., Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 291: H379-84.
22. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D., Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 2005; 12: 60-7.
23. Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, Liang X, Valentine C, Hellman J, Hayden D, Cavaillon JM., Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis 2010; 201: 223-32.
24. Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T., High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med 2008; 34: 361-7.
25. Liu X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, Van de Werf F, Bloch KD, Janssens S., Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 2007; 50: 808-17.
26. Maurenbrecher H, Lamy M, Deby-Dupont G, Frascarolo P, Hedenstierna G., An animal model of response and nonresponse to inhaled nitric oxide in endotoxin-induced lung injury. Chest 2001; 120: 573-81.
27. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE., The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280-7.
28. Soop A, Johansson C, Hjemdahl P, Kristiansson M, Gyllenhammar H, Li N, Sollevi A., Adenosine treatment attenuates cytokine interleukin-6 responses to endotoxin challenge in healthy volunteers. Shock 2003; 19: 503-7.
29. Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, Abraham E, Kitajima M, Ishizaka A., Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery? Dis Esophagus 2006; 19: 5-9.
30. Santos AA, Scheltinga MR, Lynch E, Brown EF, Lawton P, Chambers E, Browning J, Dinarello CA, Wolff SM, Wilmore DW., Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg 1993; 128: 138-43; discussion 43-4.
31. Af Klint E, Grundtman C, Engstrom M, Catrina AI, Makrygiannakis D, Klareskog L, Andersson U, Ulfgren AK., Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis Rheum 2005; 52: 3880-9.
32. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP., Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berlin, Germany) 2005; 83: 876-86.
33. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA., Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-9.
34. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, Buchler MW, Weigand MA., sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008; 147: 79-83.
35. Geroldi D, Falcone C, Emanuele E., Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem 2006; 13: 1971-8.
36. Soop A, Albert J, Weitzberg E, Bengtsson A, Nilsson CG, Sollevi A., Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia. Clin Exp Immunol 2004; 135: 114-8.
37. Albert J, Harbut P, Zielinski S, Ryniak S, Gillis-Haegerstrand C, Lindwall R, Solski L, Lundberg JO, Svensson J, Gozdzik W., Prolonged exposure to inhaled nitric oxide does not affect haemostasis in piglets. Intensive Care Med 2007; 33: 1594-601.
38. Mathru M, Huda R, Solanki DR, Hays S, Lang JD., Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 2007; 106: 275-82.
39. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Fallon MB, Bynon JS, Eckhoff DE, Patel RP., Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007; 117: 2583-91.